Overview

Company Profile

MYOS RENS is an emerging BioNutrition and BioTherapeutics  company focused on the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases.

View Detailed Stock Data

Stock Snapshot

MYOS Symbol
NASDAQ Market
Market Cap
Price
Change
Volume
View IR Calendar

Events

2017 Annual Meeting of Stockholders

45 Horsehill Road, Suite 106, Cedar Knolls, New Jersey 07927